UNSPSC 51131508: Epoetin alfa

This classification denotes a chemotherapy regimen used to treat non-hodgkins lymphoma with the molecular formula C809H1301N229O240S5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64FS3BFH5W, more generally known as epoetin alfa. European Medicines Agency schedules epoetin alfa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06575MIG. The term ERYTHROPOIETIN is an International Non-Proprietary Name or INN. Epoetin alfa bears US NLM identifiers UMLS ID C0357126 and NCI Concept Code C2695.

UNSPSC 51131508 Epoetin alfa is a Commodity code for a pharmaceutical product — a recombinant human erythropoietin used to treat anemia — that state and local governments procure primarily through health plans, correctional facilities, and public health agencies. The single recent opportunity in the available dataset does not align with this code's scope: Sourcewell, a Minnesota cooperative purchasing entity, posted RFP #061626 on May 12, 2026 for law enforcement equipment with a response deadline of June 16, 2026. That solicitation targets counties, school districts, tribal governments, and other public entities across the United States and Canada through a cooperative vehicle, but addresses tactical and protective equipment for law enforcement rather than pharmaceutical supplies. The mismatch suggests either a tagging error in the source system or limited current activity under this Commodity code in state and local procurement databases.

No recent state or local solicitations for epoetin alfa or related erythropoietin products are supported by the provided opportunity records. Business development professionals should monitor public health agency ITBs, correctional-system healthcare contracts, and health-plan pharmaceutical procurement channels for activity under this code, but should not rely on the Sourcewell law-enforcement listing as a signal of current market openness in pharmaceutical procurement.